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306 hospital referral regions for the purpose of the analy-
ses on the basis of where Medicare patients were hospital-
ized for major cardiovascular and neurosurgical
procedures using the 3436 geographic hospital service
regions defined earlier. These hospital service areas repre-
sent local health care markets for community inpatient
care. The diagnostic and surgical procedures were identi-
fied with the Part B File and the Current Procedural
Terminology (CPT) codes. These codes included 35301
for CEA (thromboendarterectomy, carotid) and 35081
(repair defect of artery, abdominal aorta), 35091 (repair
defect of artery, aorta, involving visceral vessels), and
35102 (repair defect of artery, aorta, involving iliac ves-
sels) for elective AAA repair. The physician pool or work-
force was determined by identifying physicians who
performed at least two vascular procedures on Medicare
patients during 1996 using the Part B File and the CPT
codes with the Unique Physician Identifier Number
(UPIN) File. Vascular surgeons were identified by board
certification from the American Board of Medical
Specialties. Cardiothoracic surgeons were identified when
they performed at least two coronary artery bypass graft-
ing procedures, neurosurgeons were identified by their
own self-declared subspecialty, and the remaining sur-
geons who performed at least two vascular procedures
were considered to be general surgeons. Mortality was
defined as 30-day mortality, regardless of whether patients
died in the hospital or the outpatient setting, and the mor-
tality rates were adjusted for race, sex, and age, but not for
comorbidities. Mortality was compared with hospital vol-
ume for CEA and with both surgeon volume and subspe-
cialty for CEA and elective AAA repair.
Results
Carotid endarterectomy. The overall mortality rate
after CEA across the country among Medicare patients
was not reported. However, the mortality rate after CEA
was shown to vary by both hospital and surgeon proce-
dural volume. The 30-day mortality rate during 1992 and
1993 ranged from 2.5% among low-volume hospitals to
1.7% among high-volume hospitals, and it was 1.5%
among those institutions that participated in the North
The Dartmouth Atlas of Vascular Health Care has
attempted to define the epidemiology of vascular care
across the United States for Medicare patients during
1996 and 1997. The vascular health care workforce, deter-
mined from the physicians that provide care to Medicare
patients, will be reviewed in a subsequent article. This
review focuses on the impact of hospital volume, surgeon
volume, and training on variations in outcome across the
country. The analyses focus primarily on carotid endar-
terectomy (CEA) and elective abdominal aortic aneurysm
(AAA) repair, with mortality being the main outcome
measure which reflects the emphasis in the text. Outcome
after lower-extremity arterial revascularization and the var-
ious hemodialysis access procedures/interventions were
not addressed in depth and will be discussed only briefly,
as was done in the Atlas.
SUMMARY
Methods
Data used in the analyses were obtained from a variety
of sources and encompassed patient-, hospital-, and
provider-specific databases. The Medicare files obtained
from the Health Care Finance Administration (HCFA)
included the Denominator File, the MEDPAR File, and
the Part B Standard Analytical Variable Length File. The
Denominator File includes a record for each beneficiary,
complete with demographics, eligibility, and mortality.
The MEDPAR File includes a record for each hospital
admission, whereas the Part B File includes physician/sup-
plier claims for services paid. The country was divided into
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American Symptomatic Carotid Endarterectomy Trial or
Asymptomatic Atherosclerotic Study (Fig 1). Unfortun-
ately, the criteria for hospital volume were not specified.
Similarly, the mortality rate in 1996 ranged from 2.8%
among those surgeons who performed fewer than four
procedures (low-volume surgeons) to 1.4% for those who
performed more than 42 procedures (high-volume sur-
geons; Fig 2). Twenty-four percent of the CEAs in 1996
were performed by low-volume surgeons (< 13 CEAs per
year in Medicare patients), and the proportion performed
by the low-volume surgeons varied dramatically among
the 306 hospital referral areas, with low-volume surgeons
performing 40% or more of the procedures in 42 areas.
Vascular surgeons performed 35% of the CEAs among
Medicare patients in 1996 and were followed in descend-
ing order by cardiothoracic surgeons (33%), general sur-
geons (26%), and neurosurgeons (6%). The type of
specialist that performed the plurality of the CEAs varied
by the hospital referral region (cardiothoracic, 131
regions; vascular, 104 regions; general, 59 regions; neuro,
11 regions), with vascular surgeons predominating in the
Northeast and Mid-Atlantic states and cardiothoracic sur-
geons predominating in the South and Rocky Mountain
West. The procedural mortality rate for CEA in 1996 also
varied by surgeon subspecialty and was 1.4% for neurosur-
geons, 1.5% for vascular surgeons, 1.7% for general sur-
geons, and 1.9% for cardiothoracic surgeons. However,
the volume of procedures performed by a surgeon was
found to be a stronger determinant of mortality than sur-
geon subspecialty; mortality decreased with the volume of
CEAs among all four subspecialties and was comparable
among those performing more than 24 procedures (Fig
3). Similarly, low-volume surgeons had higher mortality
rates after CEA in 1996, regardless of subspecialty.
Vascular surgeons performed a mean of 25 CEAs in
Medicare patients during 1996, and only 36% were con-
sidered to be low-volume surgeons. In contrast, more
than 60% of surgeons from the other three subspecialties
(cardiothoracic, 63%; neurosurgery, 75%; general surgery,
78%) performing CEA were considered to be low-volume
surgeons during 1996.
AAA repair. Many of the trends identified for
Medicare patients undergoing CEA were also seen among
those undergoing elective, open AAA repair. The overall
30-day mortality rate in 1996 was 5.5% and was impacted
dramatically by surgeon volume. The mortality rate
ranged from 7.9% to 4.0% among surgeons performing
fewer than four AAA repairs and surgeons performing
more than 10 AAA repairs, respectively (Fig 4). Sixty per-
cent of all surgeons who performed elective AAA repairs in
1996 were considered to be low-volume surgeons (< 4
AAA repairs per year in Medicare patients). They
accounted for 24% of the total number of AAA repairs
done, and low-volume surgeons performed 40% or more
of the elective AAA repairs in 41 hospital referral regions.
Vascular surgeons performed 39% of all elective AAA
repairs and were followed by cardiothoracic surgeons
(33%) and general surgeons (28%). The type of surgeon
performing the plurality of elective AAA repairs varied by
hospital referral region, with the cardiothoracic surgeons
predominating (cardiothoracic, 122 regions; vascular, 113
regions). General surgeons (39%) performed the largest
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Fig 1. Relationship between hospital volume and 30-day mortal-
ity rate after carotid endarterectomy from 1992 to 1993 among
Medicare patients is shown. Hospitals are broken down by proce-
dural volume (low, medium, high) or participation in carotid
endarterectomy trials (North American Symptomatic Carotid
Endarterectomy Trial or Asymptomatic Carotid Atherosclerosis
Study). (Reprinted with permission from Cronenwett JL,
Birkmeyer JD. The Dartmouth atlas of vascular health care.
Chicago: AHA Press; 2000. p. 49. Copyright 2000, Trustees of
Dartmouth College.)
Fig 2. Relationship between annual surgeon procedural volume
and 30-day mortality rate after CEA during 1996 among
Medicare patients is shown. Note that annual number of proce-
dures per surgeon includes only those performed on Medicare
patients. (Reprinted with permission from Cronenwett JL,
Birkmeyer JD. The Dartmouth atlas of vascular health care.
Chicago: AHA Press; 2000. p. 50. Copyright 2000, Trustees of
Dartmouth College.)
number of ruptured AAA repairs during 1996 and were
followed by the vascular (33%) and cardiothoracic (29%)
surgeons. The mortality rate for elective AAA repair varied
by surgeon subspecialty (vascular, 4.4%; cardiothoracic,
5.4%; general, 7.3%) in 1996, although the differences
were again largely caused by procedural volume. The mor-
tality rates varied inversely with the procedural volume for
both vascular and general surgeons and were fairly dra-
matic for the latter subspecialty (Fig 5). Vascular surgeons
performed a mean of 7.6 elective AAA repairs during
1996, and only 36% performed fewer than 6 repairs,
whereas 66% of cardiothoracic surgeons and 80% of gen-
eral surgeons fell below this level. No data regarding the
impact of hospital volume on outcome after AAA repair
were included in the Atlas.
Lower-extremity arterial occlusive disease and
hemodialysis access. The outcome assessments after
lower-extremity revascularization and operations for
hemodialysis access in the Atlas were incomplete and fairly
indirect. Specifically, no assessments of mortality, graft
thrombosis, postprocedural amputation rate, access fail-
ure, or other complications were included. There was a
substantial increase in the number of lower-extremity
revascularizations between 1993 and 1996, with the rates
for angioplasty up 38% and the rates for surgical bypass
grafting up 16% (Fig 6). However, the rate of major
lower-extremity revascularization did not decrease during
the same interval and actually increased slightly. Thirty-
nine percent of all infrainguinal bypass grafting procedures
performed during 1996 and 1997 were constructed with
synthetic grafts, a potential indirect indicator for poor
long-term outcome. The incidence ranged from 16% to
77% among the hospital referral regions, with synthetic
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grafts being used 60% of the time or more in 20 regions.
Vascular surgeons performed the largest percentage of the
lower-extremity revascularizations (vascular, 42%; general,
33%; cardiothoracic, 24%), and the breakdown by surgical
subspecialty for aortoiliac and infrainguinal revasculariza-
tion were comparable, although vascular surgeons per-
formed a larger percentage (52%) of the infrageniculate
bypass grafting procedures. Vascular surgeons performed
infrainguinal bypass grafting procedures with synthetic
grafts 30% of the time, whereas cardiothoracic and general
surgeons used synthetic conduits 49% and 41% of the
time, respectively. Eighty-three percent of all initial
hemodialysis procedures performed during 1996 and
1997 were performed with arteriovenous grafts, which are
also generally considered to have a poorer long-term out-
come than arteriovenous fistulae. The incidence of arterio-
venous grafts across the hospital referral regions ranged
from 27% to 97%, with arteriovenous grafts being used
90% of the time or more in 38 of the regions. As expected,
the proportion of access procedures performed with arte-
riovenous grafts correlated with the number of access revi-
sions on a hospital referral region level during 1996 and
1997, although the R2 value was only 0.13. General sur-
geons performed the largest percentage of the initial
hemodialysis access procedures during 1996 (general,
56%; vascular, 26%; cardiothoracic, 18%), and the break-
down by surgeon subspecialty for arteriovenous fistulae
and grafts was similar to the overall proportion.
DISCUSSION
The 30-day mortality rates reported for both CEA
(range, 1.4%-2.8% by surgeon volume) and elective AAA
repair (5.5%) in the Atlas are within the range of several
Fig 3. Relationship between annual surgeon procedural volume
and 30-day mortality rate after CEA during 1996 among
Medicare patients is shown for various subspecialties. Note that
annual number of procedures per surgeon includes only those
performed on Medicare patients. (Reprinted with permission
from Cronenwett JL, Birkmeyer JD. The Dartmouth atlas of vas-
cular health care. Chicago: AHA Press; 2000. p. 55. Copyright
2000, Trustees of Dartmouth College.)
Fig 4. Relationship between annual surgeon procedural volume
and 30-day mortality rate after elective AAA repair during 1996
among Medicare patients is shown. Note that annual number of
procedures per surgeon includes only those performed on
Medicare patients. (Reprinted with permission from Cronenwett
JL, Birkmeyer JD. The Dartmouth atlas of vascular health care.
Chicago: AHA Press; 2000. p. 73. Copyright 2000, Trustees of
Dartmouth College.)
statewide and national series. Perler et al1 reported a 0.9%
postoperative mortality rate for all patients undergoing
CEA in Maryland from 1990 to 1995, whereas Kresowik
et al2 reported an overall mortality rate of 1.5% with a
combined 30-day stroke/mortality rate for Medicare
patients undergoing CEA in 10 states from June 1995 to
May 1996. Similarly, Dardik et al3 reported a 3.5% in-
hospital mortality rate for elective AAA repair in Maryland
from 1990 to 1995, whereas Huber et al4 reported a 4.2%
mortality rate for intact AAA repairs across the United
States from 1994 to 1996. The reported mortality rates in
the Atlas are predictably higher than the perioperative
rates reported from the North American Symptomatic
Carotid Endarterectomy Trial (0.6%),5 the Asymptomatic
Carotid Atherosclerosis Study (0.4%),6 and the Veterans
Affairs Aneurysm Detection and Management Study
(1.8%),7 although they are within the range of the United
Kingdom Small Aneurysm Trial (5.8%).8 These differences
with the national trials likely reflect both the patient and
surgeon selection process.
The results in the Atlas must be interpreted with some
caution. Much of the data were obtained from administra-
tive databases that were not designed to answer specific
clinical questions. These databases often lack important
clinical data, such as the indications for the operative pro-
cedure (eg, symptomatic, nonruptured aneurysm) and the
complete list of comorbidities, both of which have a sig-
nificant potential impact on perioperative outcome and
the threshold for acceptable outcomes. For example, the
recommended combined stroke and mortality rate for
CEA performed for an asymptomatic stenosis is less than
3%, whereas the recommended combined stroke and mor-
tality rate for stroke in evolution is less than 10%.9
Furthermore, operative mortality, although reasonably
accurate, is a single, limited outcome measure. The inci-
dence of stroke, cranial nerve injury, and neck hematoma
are likewise important outcome measures after CEA,
whereas myocardial infarction, duration of ventilator
dependence, and renal failure are important measures after
AAA repair. The results and the conclusions from the
Atlas are also restricted to the Medicare population in
1996 and 1997. The observations may or may not apply
to other patient populations or to more recent years. The
authors of the Atlas estimated that 30% of all the major
vascular surgical procedures were performed on patients
younger than 65 years. Finally, the AAA repairs do not
include the endovascular repairs that have revolutionized
the approach to infrarenal aneurysms since the approval of
two endograft systems by the Food and Drug
Administration in late 1999 and may not reflect the more
recent improvements in perioperative care, including the
routine use of preoperative β-blockade.10
It is unfortunate that the authors of the Atlas did not
perform a more in-depth outcome analysis of the proce-
dures performed for lower-extremity arterial occlusive dis-
ease or hemodialysis access. Only a limited number of
outcome reports for these procedures have been published
using statewide or nationwide databases. Notably,
Mannheim et al11 analyzed the vascular surgery volume in
California from 1982 to 1994 and reported that the in-
hospital mortality rate for lower-extremity arterial bypass
grafting decreased during the interval, with a rate of 3.3%
from 1990 to 1994. They also reported that the mortality
rate varied inversely with the hospital volume and that
peripheral angioplasty did not appear to substitute for
operative revascularization. Pearce et al12 reported that
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Fig 5. Relationship between annual surgeon procedural volume
and 30-day mortality rate after elective AAA repair during 1996
among Medicare patients is shown for the various subspecialties.
Note that annual number of procedures per surgeon includes only
those performed on Medicare patients. (Reprinted with permis-
sion from Cronenwett JL, Birkmeyer JD. The Dartmouth atlas of
vascular health care. Chicago: AHA Press; 2000. p. 79. Copyright
2000, Trustees College.)
Fig 6. Rates of lower-extremity angioplasty, surgical bypass graft-
ing, and major amputation from 1993 to 1996 among Medicare
patients are shown and expressed per 1000 Medicare enrollees.
(Reprinted with permission from Cronenwett JL, Birkmeyer JD.
The Dartmouth atlas of vascular health care. Chicago: AHA Press;
2000. p. 91. Copyright 2000, Trustees of Dartmouth College.)
increased surgeon volume was associated with better out-
comes after lower-extremity arterial bypass grafting proce-
dures conducted in Florida from 1992 to 1996, although
hospital volume and surgeon specialty certification had no
impact. Additionally, Kantonen et al13 reported that the
30-day postoperative amputation rate after lower-extrem-
ity bypass grafting was related to surgeon and hospital
volume. Determining outcome after both lower-extremity
arterial revascularizations or hemodialysis access proce-
dures is more difficult than after CEA or AAA repair.
Indeed, the number of potential procedures is greater,
many of the access procedures are performed in an outpa-
tient setting, and the decision making process is often
more complex. For example, the decision algorithm for
patients with lower-extremity arterial occlusive disease
includes the timing of intervention, utility of limb salvage,
type of revascularization (endovascular or open surgical),
inflow source, outflow target, and conduit. The variable
incidence of synthetic infrainguinal bypass grafts and arte-
riovenous grafts by hospital referral areas reflects the het-
erogeneity of the approaches across the country, whereas
the disturbingly high overall incidences suggest that the
long-term outcomes may be suboptimal.
The observation that outcome improves with hospi-
tal and surgeon volume is intuitive and fairly consistent
across many complex surgical procedures. A recent sys-
tematic review of eight procedures, including CEA and
AAA repair, that was presented at an Institute of
Medicine workshop dealing with the volume-outcome
relationship in health care found that higher volume was
associated with better outcome in three fourths of the
studies.14 Furthermore, none of the studies showed a
negative impact of volume (ie, higher volume associated
with poorer outcome). Hannan et al15 analyzed 28,207
patients undergoing CEA in the state of New York from
1990 to 1995 and reported that low annual surgeon (<
5) and hospital (≤ 100) volumes were independently
associated with increased mortality rates by means of
multivariate analysis. Cebul et al16 found a similar rela-
tionship between hospital volume and nonfatal stroke or
death after CEA among Medicare beneficiaries in Ohio
from July 1993 to June 1994 and reported that the pro-
cedural indications and distribution of comorbidities
were similar between the high- and low-volume institu-
tions. Furthermore, Pearce et al12 reported that both
surgeon and hospital volume were likewise related to
outcome (death, myocardial infarction, stroke) after
CEA and intact AAA repair in the state of Florida from
1992 to 1996.
The explanation for the consistent relationship be-
tween volume and outcome after both CEA and AAA
repair remains poorly defined. Admittedly, volume is not a
specific marker of quality, because high-volume surgeons
may have bad outcomes and low-volume surgeons may
have good outcomes. Volume is likely a marker for system
factors that favorably impact care. The potential system
factors include features of the intensive care unit, surgeon
qualification, and how the operation was conducted.
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Pronovost et al17 reported that intensive care units in
which the physician did not make daily rounds were asso-
ciated with a three-fold increase in mortality after AAA
repair in Maryland hospitals from 1994 to 1996. Pearce et
al12 reported that surgeons certified in vascular surgery
had better outcomes after CEA and AAA repair, although
this observation was not supported in the Atlas after cor-
rection for surgeon volume. Additionally, Kresowik et al2
reported preoperative antiplatelet therapy, intraoperative
heparin use, and patch angioplasty were associated with a
lower incidence of adverse events by means of multivariate
analysis in their multistate study of outcome after CEA.
The consistent relationship between both hospital vol-
ume and surgeon volume with outcome suggests that the
major vascular surgical procedures should be concentrated
in specific centers. However, the use of volume as a marker
of quality is potentially problematic for several reasons.
Some low-volume surgeons have good outcomes, whereas
some high-volume surgeons have poor outcomes, as
aforementioned. Within the low-volume surgeon group
there are likely some excellent surgeons at the ends of their
careers and some junior surgeons who have recently fin-
ished their training with state-of-the-art skills that are in
the process of developing a practice. Specific hospital/sur-
geon volume criteria for the major vascular procedures
have not been defined, and the volume criteria used in the
Atlas reflect only those procedures performed on
Medicare patients, not the total hospital/surgeon volume.
Additionally, the hospital/surgeon outcomes published in
the Atlas for 1996 may not be the same today. Despite
these limitations, there is a disturbingly high percentage 
of major vascular surgical procedures performed by low-
volume surgeons with significantly higher mortality rates.
Concentrating the experience at high-volume centers or
with high-volume surgeons or both would potentially save
many lives and have a favorable economic impact. Indeed,
the Leapfrog Group, a consortium of Fortune 500 com-
panies and other large health care purchasers, has adopted
evidence-based hospital referral criteria to allow their
members to select the best hospital for procedures.18
Their standards include an annual hospital volume of 30
or more for AAA repair and 100 or more for CEA.
Similarly, the American College of Surgeons has recom-
mended minimum hospital/surgeon criteria for trauma
patients, and it is possible to envision similar recommen-
dations for major vascular procedures. The ideal solution
to the volume-outcome controversy and the delivery of
care is to identify the system markers associated with qual-
ity and to implement these into routine practice across the
country.
The recurrent themes of an increasing use of vascular
procedures and the marked geographic variability in treat-
ment highlighted in the Atlas emphasize the need to fur-
ther define outcome in an effort to improve care. The
widespread variability in care is typified by the synthetic
infrainguinal and arteriovenous grafts aforementioned and
the tremendous range in the incidence of vascular proce-
dures highlighted in the text. Notably, the incidence of
CEA and vena caval filters varies 7-fold and 18-fold,
respectively, across the country, despite little geographic
variation among the incidences of colon resection or hos-
pitalization for hip fractures. This variability in care reflects
a lack of consensus among vascular care providers, and it
is inherent on the next generation to build on the findings
in the Atlas and generate the appropriate studies required
by evidence-based medicine to standardize and improve
the care.
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